Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05005299
Title Venetoclax in Combination With Non-myeloablative Conditioning Allogeneic Haematopoietic Stem Cell Transplantation (VICTORY)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Melbourne Health
Indications

chronic lymphocytic leukemia

indolent plasma cell myeloma

myelodysplastic syndrome

non-Hodgkin lymphoma

acute leukemia

Therapies

Cyclophosphamide + Fludarabine + Venetoclax

Age Groups: adult | senior
Covered Countries


No variant requirements are available.